Carcinoma in situ of the skin of the left eyelid, including the canthus, is a non-invasive malignancy characterized by abnormal growth of epithelial cells. This condition is primarily caused by prolonged sun exposure and is clinically significant due to its potential to progress to invasive cancer if left untreated. Accurate coding with ICD-10 Code D04.12 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage this condition effectively.
ICD-10 Code D04.12 specifically denotes carcinoma in situ of the skin of the left eyelid, including the canthus. This code is used to document a localized, non-invasive cancer that has not spread beyond the epidermis. It is crucial for clinical documentation and billing, particularly when distinguishing between benign and malignant skin lesions, and ensuring appropriate treatment and follow-up.
Carcinoma in situ of the skin of the left eyelid, including the canthus, arises from the uncontrolled proliferation of keratinocytes due to factors such as UV radiation exposure. This condition requires prompt medical attention to prevent progression to invasive carcinoma. Early detection and treatment are vital for favorable outcomes.
ICD-10 Code D04.12 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.
In SOAP notes, ICD-10 Code D04.12 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ. This code is essential for maintaining continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of carcinoma in situ of the skin of the left eyelid, including canthus, typically involves surgical intervention. Prompt treatment is crucial to prevent progression.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D04.12 is critical in medical billing, particularly in hospital and outpatient settings, to ensure accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 11400 | Excision, benign skin lesion, face, ears, scalp, neck; excised diameter up to 1.0 cm. |
| 11100 | Biopsy of skin, excisional, including closure. |
| 99213 | Established patient office visit, Level 3. |
Common Questions About Using ICD-10 Code D04.12 for Carcinoma in situ of skin of left eyelid, including canthus
What are the common symptoms of carcinoma in situ of the eyelid?
Common symptoms include the appearance of a scaly or crusted lesion on the eyelid, which may be asymptomatic or cause mild irritation. Patients may also report changes in the skin texture or color.
How is carcinoma in situ of the eyelid diagnosed?
Diagnosis typically involves a physical examination followed by a biopsy to confirm the presence of atypical keratinocytes. Dermatoscopic evaluation may also assist in diagnosis.
What is the treatment for carcinoma in situ of the eyelid?
Treatment usually involves surgical excision of the lesion. Cryotherapy or topical chemotherapy may be considered in select cases. Regular follow-up is essential to monitor for recurrence.
Is carcinoma in situ of the eyelid contagious?
No, carcinoma in situ is not contagious. It is a localized skin cancer that arises from cellular changes due to factors like UV exposure, not from infectious agents.
Clinical Notes
SOAP notes
DAP notes
AI medical notes